Gaylen MacHinery Corporation v. Pitman-Moore Company

273 F.2d 340, 1959 U.S. App. LEXIS 4991
Court of Appeals for the Second Circuit·Decided December 24, 1959·No. 25572_1·Published·Cited by 3 cases

Opinion

CLARK, Circuit Judge.

This action is based on defendant’s written promise to pay a 10 per cent commission if plaintiff succeeded in obtaining an order for Salk vaccine from the Argentine Government. It was originally brought in the Supreme Court of New York and was removed to the court below by the defendant because of the diverse citizenship of the parties. At the close of plaintiff’s case defendant elected to stand on its motion for a directed verdict. The case was then submitted to a jury, which returned a plaintiff’s verdict, upon which the court entered judgment. Defendant’s motion under F.R. 50(b) for judgment or in the alternative for a new trial was denied and this appeal followed.

It is common ground that defendant promised to pay a commission and that it subsequently received an order from the Argentine Government. Since a nonexclusive agency was created the issue posed is whether the evidence was adequate to support the jury’s finding that plaintiff was the effective cause of the sale. The parties agree that New York law governs, Krasnow v. National Airlines, 2 Cir., 228 F.2d 328; Lobel v. American Airlines, 2 Cir., 192 F.2d 217, certiorari denied 342 U.S. 945, 72 S.Ct. 558, 96 L.Ed. 703, though, as we shall see, that presents no unusual features.

Since defendant’s chief attack is upon the sufficiency of the evidence we shall first turn to that. The following facts presented to the jury by the plaintiff were not contested. Defendant is a manufacturer of poliomyelitis vaccine in Indianapolis, Indiana. On November 2, 1956, Hyman Rosenstein, a partner of Mayco Chemical Co. in New York City, telephoned the defendant’s export manager that he could get an order from the Argentine Government for two million cubic centimeters of polio vaccine, with one million for immediate shipment. Defendant had previously known of Argentina’s desire to purchase vaccine, but its attempts to obtain an order had been unsuccessful. Because of the size of this proposed order it was referred to defendant’s vice-president in charge of exports and being agreed upon over the telephone, it was confirmed by telegram and an exchange of letters of November 3 and 8, 1956. Mayco was to receive a commission of 10 per cent, upon its procurement of an order from the Argentine Government for one million c.c. of poliomyelitis vaccine at a price of $5.70 per 9 c.c. vial, payment to be by irrevocable letter of credit. As “token of the buyer’s good faith” Rosenstein for Mayco deposited a check for $5,000 against the purchase of one million c.c. of polio vaccine of defendant’s manufacture packed in 9 c.c. vials.

Rosenstein then got in touch with plaintiff, Gaylen Machinery Corporation, which acted as Mayco’s subagent in the negotiations and appears herein as as-signee of all Mayco’s claims against defendant; hence the Mayco and Gaylen interests are identical for present purposes. Gaylen’s president, Weisman, had previously done business with the Argentine embassy, selling aircraft, equipment, metals, and chemicals over a number of years prior to 1956. As he testified, he then spoke to Commander Juan Bonomi at the embassy, after which he reported to Mayco and learned that defendant had the vaccine available for sale to the Argentine Government. So in November 1956, after his company had put up the $5,000 deposited with defendant, he was in touch with the Argentine embassy on “many occasions.” Pursuing the matter further, defendant on November 7, 1956, sent a telegram addressed to “Embassy of Argentina, Washington, D. C., Captain Juan Bonomi,” which read as follows:

“Reference Offer 1,000,000 CC Polio Vaccine At Five Seventy Per 9 CC Vial, *342 Made Via Gaylen, Confirm Availability Material As Offered Stop Price Five Seventy Is Our Standard Government Price”

On the same day it wired Mayco in New York, saying: “Telegraphed Argentine Embassy Washington Attention Bonomi as follows,” and quoting the above telegram. And on November 21, 1956, it wrote directly to the Ministry of Public Health in Buenos Aires, again confirming “the offer of one million cubic cc’s [sic] of Salk poliomyelitis vaccine” at the quoted price and stating explicitly: “This offer was made to the Embassy of the Argentine Republic in Washington through Gay lor (Gaylen) Machinery Corporation.” 1

Apparently the Argentine Government had made some plans to accept the offer, 2 but subsequently objected to the payment of any commissions to agents. On November 27, 1956, defendant returned the deposit to Mayco and advised it that negotiations “will not be consummated as such and that no order for this amount will be forthcoming.” This communication was supplemented by a telegram and a letter of November 28, 1956, which stated that the “order” had been “can-celled” by the Argentine Government on the ground that orders involving intermediary commissions were not in the national interest. But on the same or the following day defendant received a memorandum from the Argentine Chargé d’Affaires in Washington, D. C., which confirmed an order for two million c.c. of vaccine. Although this memorandum was dated November 28, 1956, defendant’s export manager testified that it was written during a meeting in the embassy on November 29. This sale was completed. Plaintiff, however, learned of it only several months later from accounts of the shipment in Argentine newspapers.

Free access — add to your briefcase to read the full text and ask questions with AI

Gaylen MacHinery Corporation v. Pitman-Moore Company, 273 F.2d 340, 1959 U.S. App. LEXIS 4991 (2d Cir. 1959).

273 F.2d 340 (Gaylen MacHinery Corporation v. Pitman-Moore Company) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Leen v. Butter Co.
501 N.W.2d 847 (Court of Appeals of Wisconsin, 1993)
Sears v. Teamsters Local Union No. 243
683 F.2d 154 (Sixth Circuit, 1982)